Kolkman Jeroen J, Mensink Peter B F
Medisch Spectrum Twente, Department of Internal Medicine and Gastroenterology, P.O. Box 50.000, KA Enschede 7500, The Netherlands.
Best Pract Res Clin Gastroenterol. 2003 Jun;17(3):457-73. doi: 10.1016/s1521-6918(03)00021-0.
Non-occlusive mesenteric ischaemia is characterized by gastrointestinal ischaemia with normal vessels. In gastroenterology it is recognized as rare disease occasionally causing acute bowel infarction or ischaemic colitis. From intensive care literature this disorder is recognized as an early phenomenon during circulatory stress. This early mucosal ischaemia then leads to increased permeability, bacterial translocation, and further mucosal hypoperfusion. The damage is produced mainly during reperfusion following ischaemia with fresh inflow of oxygen and outflow of waste products into the systemic circulation. The mechanisms underlying non-occlusive mesenteric ischaemia include macrovascular vasoconstriction, hypoperfusion of the tips of the villi and shunting. It is very common in critically ill and perioperative patients, but also occurs in pancreatitis, renal failure and sepsis. Treatment options include aggressive fluid resuscitation and careful choice of vasoactive drugs. Control of reperfusion damage and new endothelin-antagonists are potentially useful new treatment options.
非闭塞性肠系膜缺血的特征是胃肠道缺血但血管正常。在胃肠病学中,它被认为是一种罕见疾病,偶尔会导致急性肠梗死或缺血性结肠炎。从重症监护文献来看,这种病症被认为是循环应激期间的一种早期现象。这种早期的黏膜缺血随后会导致通透性增加、细菌移位以及进一步的黏膜灌注不足。损伤主要在缺血后的再灌注过程中产生,此时新鲜氧气流入且代谢废物流出进入体循环。非闭塞性肠系膜缺血的潜在机制包括大血管血管收缩、绒毛尖端灌注不足和分流。它在危重症患者和围手术期患者中非常常见,但也会发生在胰腺炎、肾衰竭和脓毒症患者中。治疗选择包括积极的液体复苏以及谨慎选择血管活性药物。控制再灌注损伤和新型内皮素拮抗剂是潜在有用的新治疗选择。